Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1CNS 1

Conditions

Lymphoma 3Sarcoma 1Recurrence 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Rituximab 1371Cyclophosphamide 1297Vincristine 662Doxorubicin 583Etoposide 525Prednisone 505Cytarabine 481fludarabine 462Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × gallium nitrate × Lymphoid × Clear all
NCT00002578 2015-10-06

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Roswell Park Cancer Institute

Phase 2 Completed
35 enrolled
Lymphoid

Lymphoma

NCT00002543 2013-07-18

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
CNSLymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Dendritic Cell Sarcoma, Interdigitating

NCT00054808 2006-02-08

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

Genta Incorporated

Phase 2 Completed
40 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡